Wednesday, November 18, 2026
FDA GUIDANCENovember 05, 2026

FDA CDRH 510(k) Clearance (K260674): Atellica IM Vitamin D Total II (VitDII) by Siemens Healthcare Diagnostics, Inc.

Affected Product:Atellica IM Vitamin D Total II (VitDII)
Recalling Firm / Manufacturer:Siemens Healthcare Diagnostics, Inc.
Reference / Recall Number:K260674
Executive Summary:

FDA issues 510(k) premarket notification clearance for Atellica IM Vitamin D Total II (VitDII) (K260674) manufactured by Siemens Healthcare Diagnostics, Inc..

The FDA Center for Devices and Radiological Health (CDRH) has finalized premarket notification review under Section 510(k) for Atellica IM Vitamin D Total II (VitDII).

Premarket Clearance Dossier

  • Submission Number: K260674
  • Applicant / Sponsor: Siemens Healthcare Diagnostics, Inc.
  • Device Trade Name: Atellica IM Vitamin D Total II (VitDII)
  • Product Code: MRG
  • Advisory Committee: Clinical Chemistry
  • Regulatory Decision: Substantially Equivalent

The FDA determined that the device is substantially equivalent to legally marketed predicate devices for the indications specified in the submission summary.

Official Regulatory Docket:Open Agency Docket